Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GCK | P35557 | 2/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MET | P08581 | 2/20 | 0.37 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.34 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | PLAU | P00749 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | KRAS | P01116 | 1/20 | 0.34 |
| ▸ | TSPO | P30536 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18920773 | 0.81 | GCK (0.40) | KMT2AGCKEGLN1RAB9AMET | |
| SCHEMBL12489523 | 0.80 | KMT2A (0.39) | KMT2AGCKEGLN1RAB9AMET | |
| SCHEMBL18920687 | 0.78 | GCK (0.34) | GCKEGLN1 | |
| SCHEMBL12488153 | 0.77 | EGLN1 (0.41) | KMT2AGCKEGLN1RAB9AMET | |
| SCHEMBL18920712 | 0.74 | EGLN1 (0.32) | GCKEGLN1 | |
| SCHEMBL30313283 | 0.71 | CA9 (0.57) | KMT2ARAB9AABL1SRCKRAS | |
| SCHEMBL1957640 | 0.71 | CA9 (0.57) | KMT2ARAB9AABL1SRCKRAS | |
| SCHEMBL12489917 | 0.71 | EGLN1 (0.38) | KMT2AGCKEGLN1RAB9AMET | |
| SCHEMBL9369451 | 0.70 | KMT2A (0.47) | KMT2A | |
| SCHEMBL31180945 | 0.69 | CA12 (0.37) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180368403-A1 | PYRIDINE COMPOUNDS AS FUNGICIDES | BASF SE (DE) | 2018-12-27 | — | — | US | disclosed |
| EP-3383849-A1 | PYRIDINE COMPOUNDS AS FUNGICIDES | BASF SE (DE) | 2018-10-10 | — | — | EP | disclosed |
| WO-2017093167-A1 | PYRIDINE COMPOUNDS AS FUNGICIDES | BASF SE (DE) | 2017-06-08 | — | — | WO | disclosed |
| WO-2017093167-A1 | PYRIDINE COMPOUNDS AS FUNGICIDES | BASF SE (DE) | 2017-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180368403-A1 | PYRIDINE COMPOUNDS AS FUNGICIDES | CYP4X1, CYP1A1, CYP4B1 | KMT2A 1820/4885GCK 1628/4885EGLN1 935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.